PROTEINURIA REDUCTION WITH SPARSENTAN IN IMMUNOGLOBULIN A NEPHROPATHY (IGAN): PROTECT STUDY INTERIM RESULTS

被引：0
|
作者：
Radhakrishnan, Jai [1 ]
Wong, Muh Geot [2 ,3 ]
Heerspink, Hiddo J. L. [4 ]
Komers, Radko [5 ]
Prasad, Andy [5 ]
Mercer, Alex [6 ]
机构：
[1] Columbia Univ, New York, NY USA
[2] Concord Repatriat Gen Hosp, Concord, NSW, Australia
[3] Univ Sydney, Concord Clin Sch, Camperdown, NSW, Australia
[4] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
[5] Travere Therapeut Inc, San Diego, CA USA
[6] JAMCO Pharma Consulting, Stockholm, Sweden
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2023年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
329
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [31] Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study
    Rui, Min
    Jiang, Lei
    Pan, Jia-Jun
    Huang, Xue-Ting
    Cui, Jia-Fang
    Zhang, Shi-Jia
    He, Su-Mei
    Han, Huan-Huan
    Chen, Xiao
    Wang, Dong-Dong
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (09) : 3047 - 3055
  • [32] UPDATED INTERIM RESULTS OF A PHASE 1/2 STUDY OF BION-1301 IN PATIENTS WITH IGA NEPHROPATHY
    Barratt, Jonathan
    Kooienga, Laura
    Agha, Irfan
    Ruiz-Ramon, Pablo
    Madan, Arvind
    Thomas, Hanna
    Sorensen, Bess
    Leiske, Jocelyn
    Khawaja, Zeeshan
    King, Andrew
    Jones-Burton, Charlotte
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I394 - I394
  • [33] Updated Interim Results of a Phase 1/2 Study of BION-1301 in Patients With IgA Nephropathy
    Barratt, Jonathan
    Kooienga, Laura
    Agha, Irfan
    Thomas, Hanna
    Workeneh, Biruh
    Iyer, Sai Prasad N.
    Narayanan, Rangaraj
    Sathaliya, Taher
    Sorensen, Bess
    Schwartz, Brian S.
    King, Andrew J.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 503 - 503
  • [34] Health-related quality of life in children with immunoglobulin A nephropathy - results of a multicentre national study
    Mizerska-Wasiak, Malgorzata
    Adamczuk, Dominika
    Cichon-Kawa, Karolina
    Miklaszewska, Monika
    Szymanik-Grzelak, Hanna
    Pietrzyk, Jacek A.
    Pukajlo-Marczyk, Agnieszka
    Zwolinska, Danuta
    Rybi-Szuminska, Agnieszka
    Wasilewska, Anna
    Bienias, Beata
    Sikora, Przemyslaw
    Firszt-Adamczyk, Agnieszka
    Stankiewicz, Roman
    Szczepanska, Maria
    Panczyk-Tomaszewska, Malgorzata
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (01) : 84 - 91
  • [35] Effects of ultra high dose candesartan (64mg) on proteinuria: Interim results of a double blind, randomized study
    Klingbeil, AU
    Fleischmann, EH
    Schneider, MP
    Delles, C
    Schmieder, RE
    [J]. JOURNAL OF HYPERTENSION, 2004, 22 : S79 - S80
  • [36] Felzartamab (anti-CD38) in patients with IgA Nephropathy-interim results from the IGNAZ study
    Floege, Juergen
    Lafayette, Richard
    Barratt, Jonathan
    Schwartz, Brian
    Manser, Paul T.
    Patel, Uptal D.
    Pineda, Lilia
    Faulhaber, Nicola
    Boxhammer, Rainer
    Haertle, Stefan
    Thakur, Anjali
    Barbour, Sean
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I252 - I253
  • [37] Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study
    Hadden, R.
    Andersen, H.
    Bril, V.
    Basta, I.
    Rejdak, K.
    Djordjevic, G.
    Greco, E.
    Hasan, S.
    French, J.
    Yel, L.
    Ay, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 286 - 286
  • [38] Immunoglobulin A nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review
    Joher, Nizar
    Gosset, Clement
    Guerrot, Dominique
    Pillebout, Evangeline
    Hummel, Aurelie
    Boffa, Jean-Jacques
    Faguer, Stanislas
    Rabant, Marion
    Higgins, Sarah
    Moktefi, Anissa
    Delmas, Yahsou
    Karras, Alexandre
    Lapidus, Nathanael
    Amiot, Aurelien
    Audard, Vincent
    El Karoui, Khalil
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (03) : 531 - 539
  • [39] WORK, PRODUCTIVITY, AND ACTIVITY IMPAIRMENT IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY: RESULTS FROM A REAL-WORLD STUDY
    Lafayette, R.
    Aldworth, C.
    George, A.
    De Courcy, J.
    Garratt-Wheeldon, J.
    Ndife, B.
    Kroes, M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S385 - S385
  • [40] Phase 2b ORIGIN study open label extension with atacicept in patients with IgA nephropathy and persistent proteinuria: week 72 interim analysis
    Lafayette, Richard
    Maes, Bart
    Israni, Rubeen
    Lin, Celia
    Wei, Xuelian
    Barbour, Sean
    Phoon, Richard
    Kim, Sung Gyun
    Tesar, Vladimir
    Floege, Juergen
    Jha, Vivekanand
    Barratt, Jonathan
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I53 - I55
12345